Women’s Health Update

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Harry Paul Erba, MD, PhD Guest: Uma Borate, MD, MS With the development of technologies paired with an enhanced understanding of the AML genomic landscape, it's become possible to further the development of AML therapies. Joining Dr. Charles Turck to explore venetoclax and its role in current AML treatment paradigms are Drs. Uma Borate and Harry Erba.

Guest: Ilene Galinsky BSN,MSN,ANP-C Here to review the ramp-up and dosing for venetoclax therapy in patients with newly diagnosed acute myeloid leukemia is Ilene Galinsky, Senior Program Research Nurse Practitioner for the Leukemia Program at Dana Farber Cancer Institute.

Guest: Ilene Galinsky BSN,MSN,ANP-C Patients with acute myeloid leukemia (AML) are at high risk for febrile neutropenia or profound, protracted neutropenia. So how can we monitor for the risk of neutropenia in AML patients starting venetoclax therapy? That's what Ilene Galinsky, Senior Program Research Nurse Practitioner for the Leukemia Program at Dana Farber Cancer Institute, is here to explain.

Host: Mimi Secor, DNP, FNP-BC, FAANP Guest: Maria Trent, MD, MPH, FAAP, FSAHM There are gaps in resources available to care for patients with mycoplasma genitalium (MGen). Since access to testing and to resistance testing are critical to be able to properly care for women suspected of having MGen, Dr. Mimi Secor talks with Dr. Maria Trent from Johns Hopkins School of Medicine about how clinicians can overcome common diagnostic and treatment challenges and shares guidelines updates from the CDC.

Host: Mimi Secor, DNP, FNP-BC, FAANP Guest: Maria Trent, MD, MPH, FAAP, FSAHM Dr. Mimi Secor is joined by Dr. Maria Trent to discuss mycoplasma genitalium (MGen), how we can better understand this infection and help reduce our patients' risk of it.

Host: Mimi Secor, DNP, FNP-BC, FAANP Guest: Maria Trent, MD, MPH, FAAP, FSAHM Dr. Mimi Secor is joined by Dr. Maria Trent, Chief of the Division of Adolescent and Young Adult Medicine at Johns Hopkins School of Medicine, to discuss diagnosing and treating antibiotic resistant MGen.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Paul Nyirjesy, MD Guest: Christina Muzny, MD Diagnosing vaginal infections early and accurately is key, but are current testing methods for vaginal infections facilitating early diagnosis? Joining Dr. Charles Turck to help answer this question are Drs. Christina Muzny and Paul Nirjesky, who share their multidisciplinary viewpoints on vaginal infections and diagnostic practices in women's health.

Guest: Barbara Van Der Pol, PhD, MPH Dr. Barbara Van Der Pol, a Professor of Medicine in Infectious Diseases at The University of Alabama at Birmingham and Scientist at the Center for Women's Reproductive Health briefly discusses how rapid testing could impact the treatment landscape for sexually transmitted infections.

Guest: Barbara Van Der Pol, PhD, MPH Dr. Barbara Van Der Pol, a Professor of Medicine in Infectious Diseases at The University of Alabama at Birmingham and Scientist at the Center for Women's Reproductive Health briefly discusses how rapid testing could impact the treatment landscape for sexually transmitted infections.

Host: Jay Wohlgemuth, MD Guest: Felice Gersh, MD The number one cause of death for women in the United States is cardiovascular disease. Luckily, providers can help identify their patients’ risk and educate them on the preventive measures available that can help mitigate their risk. Listen in as Dr. Jay Wohlgemuth speaks with Dr. Felice Gersh about diagnostic tests available for women today.

Host: Matt Birnholz, MD Guest: Stephen Hiscox, PhD Though statins have long been used for the treatment of hypercholesterolemia, growing evidence suggests they may also have a role in lowering the risk of breast cancer development. But how they potentially do this and whether all statins are equal to that task was the focus of Dr. Matt Birnholz’s discussion with Dr. Stephen Hiscox at the 2019 San Antonio Breast Cancer Symposium.

Host: Matt Birnholz, MD Guest: Lauren Nye, MD Considering there’s little known about the breast microenvironment during pregnancy and whether this plays into future breast cancer risk, Dr. Lauren Nye's team examined whether omega 3 supplements as potential non-teratogenic chemoprevention agents could accentuate the protective changes on breast cancer risk that occur with hormonal fluctuations during pregnancy. And Dr. Matt Birnholz was there at the 2019 San Antonio Breast Cancer Symposium to catch up with Dr. Nye about this study.

Host: Matt Birnholz, MD Guest: Nadine Tung, MD Recorded live at the 2019 San Antonio Breast Cancer Symposium, Dr. Matt Birnholz sat down with Dr. Nadine Tung, Associate Professor of Medicine at Harvard Medical School and Director of the Cancer Risk and Prevention Program at Beth Israel Deaconess Medical Center, to talk about her presentation on genetic testing for hereditary breast cancer.

Host: Matt Birnholz, MD Guest: Marina Kaplan, PhD Ms. Marina Kaplan's inspiring life history as an "outlier survivor" as she put it for having achieved remission from triple-negative breast cancer over six years ago was helped by numerous cutting-edge clinical trials made accessible to her. But the experience as a study subject exposed her to systemic barriers confronting breast cancer patients everywhere, compelling her to reprise her epidemiology career expertise in conducting a study looking for novel solutions, as she shares with Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

Host: Matt Birnholz, MD Guest: Daniela Rosa, MD To learn more about the effects of dietary interventions after early breast cancer treatment and the current gaps that exist in systemic reviews that assess those effects, Dr. Matt Birnholz sat down with Dr. Daniela Rosa at the 2019 San Antonio Breast Cancer Symposium.

Host: Matt Birnholz, MD Guest: Stephen Hiscox, PhD Though statins have long been used for the treatment of hypercholesterolemia, growing evidence suggests they may also have a role in lowering the risk of breast cancer development. But how they potentially do this and whether all statins are equal to that task was the focus of Dr. Matt Birnholz’s discussion with Dr. Stephen Hiscox at the 2019 San Antonio Breast Cancer Symposium.

Host: Matt Birnholz, MD Guest: Lauren Nye, MD Considering there’s little known about the breast microenvironment during pregnancy and whether this plays into future breast cancer risk, Dr. Lauren Nye's team examined whether omega 3 supplements as potential non-teratogenic chemoprevention agents could accentuate the protective changes on breast cancer risk that occur with hormonal fluctuations during pregnancy. And Dr. Matt Birnholz was there at the 2019 San Antonio Breast Cancer Symposium to catch up with Dr. Nye about this study.

Host: Matt Birnholz, MD Guest: Nadine Tung, MD Recorded live at the 2019 San Antonio Breast Cancer Symposium, Dr. Matt Birnholz sat down with Dr. Nadine Tung, Associate Professor of Medicine at Harvard Medical School and Director of the Cancer Risk and Prevention Program at Beth Israel Deaconess Medical Center, to talk about her presentation on genetic testing for hereditary breast cancer.

Host: Matt Birnholz, MD Guest: Marina Kaplan, PhD Ms. Marina Kaplan's inspiring life history as an "outlier survivor" as she put it for having achieved remission from triple-negative breast cancer over six years ago was helped by numerous cutting-edge clinical trials made accessible to her. But the experience as a study subject exposed her to systemic barriers confronting breast cancer patients everywhere, compelling her to reprise her epidemiology career expertise in conducting a study looking for novel solutions, as she shares with Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

Host: Matt Birnholz, MD Guest: Daniela Rosa, MD To learn more about the effects of dietary interventions after early breast cancer treatment and the current gaps that exist in systemic reviews that assess those effects, Dr. Matt Birnholz sat down with Dr. Daniela Rosa at the 2019 San Antonio Breast Cancer Symposium.

Host: Matt Birnholz, MD Guest: Dawn L. Hershman, MD, MS Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

Host: Matt Birnholz, MD Guest: Dawn L. Hershman, MD, MS Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

Host: Jennifer Caudle, DO Guest: Liza Kunz, MD, FACOG Amid the expanding noninvasive prenatal testing (NIPT) options, Dr. Liza Kunz joins Dr. Jennifer Caudle to discuss what differentiates genome-wide NIPT from other options, how it works, and its limitations and potential benefits. US MSA Educational Program

Host: Jennifer Caudle, DO Guest: Liza Kunz, MD, FACOG Amid the expanding noninvasive prenatal testing (NIPT) options, Dr. Liza Kunz joins Dr. Jennifer Caudle to discuss what differentiates genome-wide NIPT from other options, how it works, and its limitations and potential benefits. US MSA Educational Program

Host: Matt Birnholz, MD Guest: Johnathan Strauss, MD Joining Dr. Matt Birnholz at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, is Dr. Jonathan Strauss to discuss the talks he’s given at this year’s conference on the evolution of radiation oncology as a field, challenging breast cancer cases, and emerging factors that support the emission of radiotherapy in invasive cancers.

Guest: Johnathan Strauss, MD Recorded live at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Jonathan Strauss, an Associate Professor of Radiation Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, shares key strategies for delivering targeted radiotherapy to avoid damaging associated tissues.

Host: Matt Birnholz, MD Guest: Kelly Scheu, MS, NP At the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Matt Birnholz caught up with Kelly Scheu, a nurse practitioner specializing in breast oncology at the University of Michigan, who shared how her spirituality and medical expertise of 27 years in the oncology field blend to enhance breast cancer care.

Host: Matt Birnholz, MD Guest: Thanos Kosmidis Tune in as Dr. Matt Birnholz talks with Thanos Kosmidis, the founder and CEO of Care Across, about the company’s new poster presentation on breast cancer patients’ quality of life at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain.

Host: Matt Birnholz, MD Guest: Johnathan Strauss, MD Joining Dr. Matt Birnholz at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, is Dr. Jonathan Strauss to discuss the talks he’s given at this year’s conference on the evolution of radiation oncology as a field, challenging breast cancer cases, and emerging factors that support the emission of radiotherapy in invasive cancers.

Guest: Johnathan Strauss, MD Recorded live at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Jonathan Strauss, an Associate Professor of Radiation Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, shares key strategies for delivering targeted radiotherapy to avoid damaging associated tissues.

Host: Matt Birnholz, MD Guest: Kelly Scheu, MS, NP At the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois, Dr. Matt Birnholz caught up with Kelly Scheu, a nurse practitioner specializing in breast oncology at the University of Michigan, who shared how her spirituality and medical expertise of 27 years in the oncology field blend to enhance breast cancer care.

Host: Matt Birnholz, MD Guest: Thanos Kosmidis Tune in as Dr. Matt Birnholz talks with Thanos Kosmidis, the founder and CEO of Care Across, about the company’s new poster presentation on breast cancer patients’ quality of life at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain.

Host: Matt Birnholz, MD Guest: Giuseppe Curigliano, MD, PhD Known for his early drug development research for breast cancer, Dr. Giuseppe Curigliano joins Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about the latest research in treatment developments for triple-negative breast cancer as well as insights on what’s coming ahead on the future horizons for this cancer subtype.

Host: Matt Birnholz, MD Guest: Susanne Ahlstedt Karlsson, PhD Get an in-depth look at the reality of the patient experience with endocrine treatment after breast cancer surgery with Dr. Matt Birnholz and Dr. Susanne Ahlstedt-Karlsson at the 2019 European Society for Medical Oncology(ESMO) Congress in Barcelona, Spain.

Host: Matt Birnholz, MD Guest: Hans Petter Eikesdal, MD At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.

Host: Matt Birnholz, MD Guest: Randi J. Reidunsdatter, MD Joining Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about his recent study titled, Agreement Between Patients and Oncologists on the Severity of the Patient’s Symptoms and Functions During a One-Year Follow-Up After Breast Cancer Treatment, is Dr. Randi Reidunsdatter.

Host: Matt Birnholz, MD Guest: Giuseppe Curigliano, MD, PhD Known for his early drug development research for breast cancer, Dr. Giuseppe Curigliano joins Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about the latest research in treatment developments for triple-negative breast cancer as well as insights on what’s coming ahead on the future horizons for this cancer subtype.

Host: Matt Birnholz, MD Guest: Susanne Ahlstedt Karlsson, PhD Get an in-depth look at the reality of the patient experience with endocrine treatment after breast cancer surgery with Dr. Matt Birnholz and Dr. Susanne Ahlstedt-Karlsson at the 2019 European Society for Medical Oncology(ESMO) Congress in Barcelona, Spain.

Host: Matt Birnholz, MD Guest: Hans Petter Eikesdal, MD At the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain, Dr. Matt Birnholz got a chance to talk with Dr. Hans Petter Eikesdal about the head-turning study on PARP inhibitors he presented at the conference.

Host: Matt Birnholz, MD Guest: Randi J. Reidunsdatter, MD Joining Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about his recent study titled, Agreement Between Patients and Oncologists on the Severity of the Patient’s Symptoms and Functions During a One-Year Follow-Up After Breast Cancer Treatment, is Dr. Randi Reidunsdatter.

Guest: Sheryl A. Kingsberg, PhD Guest: Brooke M. Faught, DNP, WHNP-BC,NCMP, IF Guest: Risa Kagan, MD, FACOG, CCD, NCMP Guest: James A. Simon, MD, CCD, NCMP, IF, FACOG An average of 37.5 million menopausal women in the US between the ages of 45 and 64 experience symptoms such as hot flashes and joint pain, but there are other symptoms that we rarely talk about: symptoms like vaginal dryness and dyspareunia. Featuring a patient and a panel of experts, this discussion reviews strategies that can be used to help patients feel comfortable in bringing up their struggles with menopause along with how we can help relieve women from their pain. ©2019 NP-INR-US-00214 09/19

Host: Amy Mackey, MD Guest: William Kutteh, MD, PhD There’s no denying that pregnancy losses are emotionally devastating to patients—especially if they happen recurrently—but knowing why can help couples cope with the loss. To help us uncover how we can provide patients with those answers, Dr. Amy Mackey is joined by Dr. William Kutteh from Fertility Associates of Memphis.